• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Virta Health Launches Cost Guarantee for GLP-1s & Weight Loss

by Jasmine Pennic 06/04/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Source Credit Virta Health

What You Should Know: 

– Virta Health, a provider of sustainable weight loss and diabetes reversal through a nutrition-first approach, today announced industry-first cost guarantees for its weight loss program. 

– These guarantees aim to eliminate financial risk for employers and health plans by ensuring Virta’s program pays for itself while also reining in the escalating costs associated with GLP-1 medications, which are reportedly rising 70–200% annually across the industry. Virta now commits to stopping these increases completely, guaranteeing 0% utilization growth for employers offering this drug class for obesity.

Tackling Soaring GLP-1 Costs and Ensuring Value for Payers

The rapidly increasing costs of GLP-1 medications for weight loss, projected to surpass $100 billion annually, are placing enormous financial pressure on employers and health plans. In response, many organizations have opted not to cover these medications for weight loss, or have discontinued coverage after experiencing spiraling costs, often leaving members dissatisfied and without access to treatment.

Virta aims to set a new standard by combining outcomes-driven care with cost-conscious, responsible GLP-1 use. The company prioritizes nutrition and utilizes high-quality, name-brand GLP-1 medications only when clinically necessary.

Virta’s Dual Cost Guarantees: A New Standard for Weight Loss Programs

Virta’s new, industry-first cost guarantees include:

  • 0% Year-over-Year Growth in GLP-1 Utilization: For organizations that offer GLP-1 coverage for obesity, Virta guarantees a 0% year-over-year cost increase related to these medications, as measured by prescription volume.
  • 1:1 Claims Based ROI: Employers and health plans are assured at least a dollar-for-dollar return in total cost of care savings, based on a rigorous analysis of medical and pharmacy claims—considered the gold standard for assessing economic impact in healthcare.

These financial assurances are complemented by Virta’s existing industry-leading clinical guarantees, which include a promise to deliver even greater weight loss across entire enrolled populations—whether or not members are using GLP-1 medications—through its Sustainable Weight Loss program with Responsible Prescribing.

A Nutrition-First Approach with Responsible GLP-1 Management

Virta emphasizes its unique position as the only solution on the market that it claims can match the weight loss results of GLP-1 medications without relying on drugs, while also guaranteeing even greater bodyweight reduction for its members. This enables members to achieve lasting results with or without GLP-1s. When medications are appropriate, Virta offers flexible solutions to help organizations secure best-in-market pricing on GLP-1s, leveraging unique partnerships with Pharmacy Benefit Managers (PBMs) and direct access to pharmaceutical manufacturers’ consumer pricing.

“These guarantees are a natural extension of our founding mission—to reverse chronic diseases like diabetes and obesity while reducing costs,” said Virta co-founder and CEO Sami Inkinen. “We’ve proven that it’s possible to achieve meaningful, sustainable weight loss with or without lifelong medication use. Now we’re taking the next step: fully aligning our incentives with our customers to help them control costs and deliver better outcomes at the same time”.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: GLP-1

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |